WEBFor patients with HCM undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of candidate’s septal perforator(s) is recommended. Establish diagnosis & determine pattern of hypertrophy.
WEBE. Mitral Regurgitation in HCM. Because the anterior leaflet motion is greater than that of the posterior leaflet during SAM, an interleaflet gap occurs, resulting in a posteriorly directed jet of mitral regurgitation, which can be significant (moderate or greater depending on the extent of the gap).
Hypertrophic cardiomyopathy: Management of patients with ... - UpToDate
WEBJul 31, 2024 · Hypertrophic cardiomyopathy (HCM) is a genetically determined disease that commonly results in obstruction of the left ventricular outflow tract (LVOT), which can produce chest discomfort, dyspnea, fatigue, and syncope. This topic discusses the management of patients with HCM and symptoms attributable to LVOT obstruction.
2020 AHA/ACC Guideline for the Diagnosis and Treatment of …
WEBNov 20, 2020 · TTE or TEE imaging helps guide alcohol septal ablation, particularly in localizing the appropriate left anterior descending septal perforator by intracoronary contrast injection as well as monitoring of LVOT gradient reduction during the procedure.
2020 AHA/ACC Guideline for Hypertrophic Cardiomyopathy: Key ...
WEBNov 20, 2020 · As a Class IIa recommendation, it is reasonable to offer an ICD for patients with massive LV hypertrophy ≥30 mm, history of suspected cardiac syncope, LV apical aneurysm, systolic dysfunction with ejection fraction (EF) <50%, or family history of sudden cardiac death due to HCM.
WEBtransesophageal echocardiogram (TEE) is recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.
Focus on echocardiography in hypertrophic cardiomyopathy - fourth …
WEB(1) HCM is a disease state characterised by unexplained, marked and asymmetric left ventricular (LV) hypertrophy associated with non-dilated ventricular chambers in the absence of another cardiac or systemic disease capable of producing the magnitude of hypertrophy evident in a given patient.
Cardiovascular monitoring in patients with hypertrophic …
WEBJan 4, 2022 · Intraoperative transesophageal echocardiography (TEE) helps patients with HOCM undergoing noncardiac surgery. However, it is sometimes unsuitable, depending on the surgery and the patient's surgical positioning.
Preintervention imaging and intraoperative management care of …
WEBSep 24, 2021 · TEE is a more reliable tool to assess fluid status intraoperatively than central venous pressure or a pulmonary artery catheter (PAC) in HOCM patients. 33 The PAC significantly overestimates the preload of this patient population, due to existing high left ventricle end-diastolic pressure or pulmonary capillary wedge pressure, induced by an ...
Hypertrophic Cardiomyopathy (HCM) • LITFL • ECG Library …
WEBMay 22, 2022 · Hypertrophic cardiomyopathy, previously termed hypertrophic obstructive cardiomyopathy (HOCM) or idiopathic hypertrophic subaortic stenosis (IHSS), is one of the most common inherited cardiac disorders: Prevalence ~1 in 500 people. Annual mortality ~1-2%. Number one cause of sudden cardiac death in young people.